Midori Mitui

1.3k total citations
31 papers, 940 citations indexed

About

Midori Mitui is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Midori Mitui has authored 31 papers receiving a total of 940 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 15 papers in Cancer Research and 9 papers in Oncology. Recurrent topics in Midori Mitui's work include DNA Repair Mechanisms (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Cancer-related Molecular Pathways (6 papers). Midori Mitui is often cited by papers focused on DNA Repair Mechanisms (11 papers), Carcinogens and Genotoxicity Assessment (7 papers) and Cancer-related Molecular Pathways (6 papers). Midori Mitui collaborates with scholars based in United States, Brazil and Australia. Midori Mitui's co-authors include Richard A. Gatti, Helen H. Chun, Chih‐Hung Lai, N. Kristine Leos, Shareef Nahas, Liutao Du, Beverly Barton Rogers, Xia Sun, Dinesh Rakheja and Paula A. Revell and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Pediatrics and Modern Pathology.

In The Last Decade

Midori Mitui

30 papers receiving 923 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Midori Mitui United States 18 608 288 160 132 103 31 940
Scott R. Brodeur United States 14 359 0.6× 244 0.8× 211 1.3× 55 0.4× 93 0.9× 24 1.6k
Julia Foldi United States 14 381 0.6× 256 0.9× 281 1.8× 90 0.7× 187 1.8× 50 1.3k
Hsin‐Pai Li Taiwan 15 409 0.7× 177 0.6× 295 1.8× 77 0.6× 55 0.5× 29 943
Thilo Schlott Germany 18 390 0.6× 116 0.4× 266 1.7× 76 0.6× 56 0.5× 51 855
Myung‐Shin Lee South Korea 18 513 0.8× 218 0.8× 195 1.2× 64 0.5× 36 0.3× 76 945
Arvind Raghavan United States 15 589 1.0× 96 0.3× 129 0.8× 63 0.5× 140 1.4× 33 1.1k
Adriana Contreras‐Paredes Mexico 19 517 0.9× 250 0.9× 219 1.4× 63 0.5× 72 0.7× 43 1.1k
Howard B. Urnovitz United States 17 328 0.5× 290 1.0× 323 2.0× 150 1.1× 91 0.9× 41 973
Kirsty Moore United Kingdom 9 273 0.4× 178 0.6× 178 1.1× 58 0.4× 176 1.7× 25 1.2k

Countries citing papers authored by Midori Mitui

Since Specialization
Citations

This map shows the geographic impact of Midori Mitui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Midori Mitui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Midori Mitui more than expected).

Fields of papers citing papers by Midori Mitui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Midori Mitui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Midori Mitui. The network helps show where Midori Mitui may publish in the future.

Co-authorship network of co-authors of Midori Mitui

This figure shows the co-authorship network connecting the top 25 collaborators of Midori Mitui. A scholar is included among the top collaborators of Midori Mitui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Midori Mitui. Midori Mitui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kapur, Payal, Hua Zhong, Midori Mitui, et al.. (2021). Germline and sporadic mTOR pathway mutations in low-grade oncocytic tumor of the kidney. Modern Pathology. 35(3). 333–343. 42 indexed citations
2.
Park, Jason Y., Kerry B. Dunbar, Midori Mitui, et al.. (2016). Helicobacter pylori Clarithromycin Resistance and Treatment Failure Are Common in the USA. Digestive Diseases and Sciences. 61(8). 2373–2380. 66 indexed citations
3.
Davies, Kurtis D., Midhat S. Farooqi, Mike Gruidl, et al.. (2016). Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation. Journal of Molecular Diagnostics. 18(4). 572–579. 19 indexed citations
4.
Smith, Debra L., Midori Mitui, Jason Y. Park, Hung S. Luu, & Charles F. Timmons. (2015). Characterization of theHBB: c.*233G > C Variant: No Evidence of aβ-Thalassemic Phenotype. Hemoglobin. 40(1). 25–28. 1 indexed citations
5.
Mitui, Midori, et al.. (2013). Long-range PCR based sequencing of the highly homologous genes, SFTPA1 and SFTPA2. Molecular and Cellular Probes. 27(3-4). 115–117. 4 indexed citations
6.
Ziadie, Mandolin, et al.. (2011). A Lean Laboratory. Journal of Molecular Diagnostics. 13(2). 175–179. 37 indexed citations
7.
Khokhar, Shama, Midori Mitui, N. Kristine Leos, Beverly Barton Rogers, & Jason Y. Park. (2011). Evaluation of Maxwell® 16 for automated DNA extraction from whole blood and formalin-fixed paraffin embedded (FFPE) tissue. Clinical Chemistry and Laboratory Medicine (CCLM). 50(2). 267–72. 16 indexed citations
8.
Cost, Nicholas G., Midori Mitui, Shama Khokhar, et al.. (2011). TP53 codon 72 polymorphisms in favorable histology Wilms tumors. Pediatric Blood & Cancer. 59(2). 326–328. 4 indexed citations
9.
Rakheja, Dinesh, Midori Mitui, Richard L. Boriack, & Ralph J. DeBerardinis. (2010). Isocitrate dehydrogenase 1/2 mutational analyses and 2‐hydroxyglutarate measurements in Wilms tumors. Pediatric Blood & Cancer. 56(3). 379–383. 21 indexed citations
10.
Rakheja, Dinesh, et al.. (2008). A subset of cranial fasciitis is associated with dysregulation of the Wnt/β-catenin pathway. Modern Pathology. 21(11). 1330–1336. 34 indexed citations
11.
Leos, N. Kristine, et al.. (2008). Comparison of Automated Nucleic Acid Extraction Methods with Manual Extraction. Journal of Molecular Diagnostics. 10(4). 311–316. 66 indexed citations
12.
Mitui, Midori, Shareef Nahas, Liutao Du, et al.. (2008). Functional and computational assessment of missense variants in the ataxia-telangiectasia mutated (ATM) gene: mutations with increased cancer risk. Human Mutation. 30(1). 12–21. 53 indexed citations
13.
14.
Mitui, Midori, Ewa Bernatowska, Barbara Pietrucha, et al.. (2005). ATM Gene Founder Haplotypes and Associated Mutations in Polish Families with Ataxia‐Telangiectasia. Annals of Human Genetics. 69(6). 657–664. 33 indexed citations
15.
Mitui, Midori, Colin Campbell, Xia Sun, et al.. (2003). Independent mutational events are rare in the ATM gene: Haplotype prescreening enhances mutation detection rate. Human Mutation. 22(1). 43–50. 49 indexed citations
16.
Buzin, Carolyn H., Richard A. Gatti, Vũ Quốc Huy Nguyễn, et al.. (2003). Comprehensive scanning of theATM gene with DOVAM-S. Human Mutation. 21(2). 123–131. 39 indexed citations
17.
Mitui, Midori, Catarina D. Campbell, Beatriz Tavares Costa‐Carvalho, et al.. (2003). Five haplotypes account for fifty‐five percent of ATM mutations in Brazilian patients with ataxia telangiectasia: Seven new mutations. American Journal of Medical Genetics Part A. 126A(1). 33–40. 23 indexed citations
18.
Campbell, Catarina D., et al.. (2002). ATM mutations on distinct SNP and STR haplotypes in ataxia-telangiectasia patients of differing ethnicities reveal ancestral founder effects. Human Mutation. 21(1). 80–85. 36 indexed citations
19.
Sun, Xia, Sara Becker-Catania, Helen H. Chun, et al.. (2002). Early diagnosis of ataxia-telangiectasia using radiosensitivity testing. The Journal of Pediatrics. 140(6). 724–731. 95 indexed citations
20.
Gatti, Richard A., Sara Becker-Catania, Helen H. Chun, et al.. (2001). The Pathogenesis of Ataxia-Telangiectasia. Clinical Reviews in Allergy & Immunology. 20(1). 87–108. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026